Dr Mehmood Khan - CEO, Hevolution Foundation

Dr. Mehmood Khan, CEO of Hevolution Foundation, discusses advancements in medicine and biotech, highlighting progress in managing diseases like diabetes and hypertension. The conversation shifts to Asia's role in healthcare innovation, particularly Japan's contributions to drug development. Dr. Khan emphasizes the importance of extending health span rather than just lifespan, focusing on maintaining functionality and independence in aging populations. He addresses the economic implications of extended health, noting the potential GDP benefits. The discussion explores how Hevolution Foundation invests in aging biology research globally, seeking solutions to age-related challenges. Concerns about potential inequalities in access to longevity technologies are raised, emphasizing the need for democratization. The conversation touches upon the role of AI in healthcare, including concerns about data privacy and ethical considerations. Dr. Khan shares an example of using aging science to treat hepatitis B, showcasing the potential of understanding the underlying processes of age-related diseases. The goal is to understand how to keep people functional in society.